Literature DB >> 15330067

Chagasic enteropathy.

Ulysses G Meneghelli1.   

Abstract

Involvement of the hollow organs of the digestive apparatus can occur in patients in the chronic phase of Chagas' disease. The basic mechanism is destruction of neurons of the enteric nervous system. Whereas megaesophagus and megacolon are the most notable and most extensively studied expressions of the digestive form of Chagas' disease, involvement of the small intestine (Chagasic enteropathy) is less frequent and less known than involvement of the two above mentioned entities. Chagasic enteropathy can be responsible for important clinical and laboratory manifestations resembling those of dyspeptic syndrome, intestinal pseudo-obstruction and bacterial overgrowth in the small intestine. Chagasic enteropathy also involves peculiar functional changes, especially those related to motor activity of the organ and to intestinal absorption of carbohydrates. In practice, the diagnosis is based on radiographic documentation of dilation of visceral segments. Treatment consists of clinical control of the above syndromes and, eventually, appropriate surgical operations.

Entities:  

Mesh:

Year:  2004        PMID: 15330067     DOI: 10.1590/s0037-86822004000300012

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  17 in total

Review 1.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

2.  Trypanosoma cruzi-Derived Neurotrophic Factor: Role in Neural Repair and Neuroprotection.

Authors:  Marina V Chuenkova; Mercio Pereiraperrin
Journal:  J Neuroparasitology       Date:  2010-07-26

Review 3.  Pediatric Intestinal Pseudo-obstruction in the Era of Genetic Sequencing.

Authors:  Heidi E Gamboa; Manu Sood
Journal:  Curr Gastroenterol Rep       Date:  2019-12-17

Review 4.  Small intestinal bacterial overgrowth syndrome.

Authors:  Jan Bures; Jiri Cyrany; Darina Kohoutova; Miroslav Förstl; Stanislav Rejchrt; Jaroslav Kvetina; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

5.  The significantly reduced number of interstitial cells of Cajal in chagasic megacolon (CM) patients might contribute to the pathophysiology of CM.

Authors:  Sheila Jorge Adad; Gisele Barbosa E Silva; Alessandro Adad Jammal
Journal:  Virchows Arch       Date:  2012-08-16       Impact factor: 4.064

Review 6.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

7.  Photoinactivation of Trypanosoma cruzi in red cell suspensions with thiopyrylium.

Authors:  Stephen J Wagner; Andrey Skripchenko; Jeanne Salata; Lisa J Cardo
Journal:  Transfus Apher Sci       Date:  2007-08-14       Impact factor: 1.764

Review 8.  White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies.

Authors:  Alan J Burns; Allan M Goldstein; Donald F Newgreen; Lincon Stamp; Karl-Herbert Schäfer; Marco Metzger; Ryo Hotta; Heather M Young; Peter W Andrews; Nikhil Thapar; Jaime Belkind-Gerson; Nadege Bondurand; Joel C Bornstein; Wood Yee Chan; Kathryn Cheah; Michael D Gershon; Robert O Heuckeroth; Robert M W Hofstra; Lothar Just; Raj P Kapur; Sebastian K King; Conor J McCann; Nandor Nagy; Elly Ngan; Florian Obermayr; Vassilis Pachnis; Pankaj J Pasricha; Mai Har Sham; Paul Tam; Pieter Vanden Berghe
Journal:  Dev Biol       Date:  2016-04-05       Impact factor: 3.582

9.  Partial, selective survival of nitrergic neurons in chagasic megacolon.

Authors:  Samir Jabari; Alexandre B M da Silveira; Enio C de Oliveira; Salustiano G Neto; Karl Quint; Winfried Neuhuber; Axel Brehmer
Journal:  Histochem Cell Biol       Date:  2010-12-24       Impact factor: 4.304

Review 10.  The chronic gastrointestinal manifestations of Chagas disease.

Authors:  Nilce Mitiko Matsuda; Steven M Miller; Paulo R Barbosa Evora
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.